Ant AI AQ Ranks 7th in China's AI App Growth
Ant Group's AI Health App AQ Climbs to 7th in China
October 28, 2025 – QuestMobile's latest industry report reveals Ant Group's AI health application AQ as the fastest-growing AI-native app in China, ranking 7th nationally just three months after launch. With an 83.4% compound growth rate in Q3 2025—far surpassing the industry average of 13.5%—AQ has become the only health-focused app in China's Top 10 AI applications.

Market Performance and Integration
The report highlights AQ's rapid ascent past established general AI products like Tongyi and Wenxiaoyan, attributed to its specialized healthcare functionality. Ant Group has accelerated integration between AQ and its Haodaifu medical platform, now accessible via Alipay's health channel. Users can leverage "AI Doctor Finder" for intelligent triage and appointment booking with Haodaifu's network of 300,000 doctors.

Strategic Healthcare Expansion
This development follows Ant Group's aggressive healthcare investments:
- January 2025: Acquired Haodaifu Online to advance "AI + Healthcare"
- March: Launched full-stack Ant Healthcare Large Model solutions
- June: Elevated AI healthcare to core business status
At September's Bund Conference, Ant CEO Han Xinyi emphasized healthcare as a priority sector for specialized AI applications: "Smart technologies must tangibly improve daily life."

Key Points:
- 🚀 83.4% growth rate leads China's Top 10 AI apps
- 🏥 Only health-focused app in elite rankings
- 🤖 Deep integration with Haodaifu enables AI-to-doctor consultations
- 💡 Part of Ant Group's strategic pivot toward vertical AI solutions